Login / Signup

Apixaban Versus Rivaroxaban in Patients With Atrial Fibrillation and Valvular Heart Disease : A Population-Based Study.

Ghadeer K DawwasAdam CukerGeoffery D BarnesJames D LewisSean Hennessy
Published in: Annals of internal medicine (2022)
National Institutes of Health.
Keyphrases
  • atrial fibrillation
  • venous thromboembolism
  • public health
  • healthcare
  • oral anticoagulants
  • mental health
  • pulmonary hypertension
  • quality improvement
  • health information
  • pulmonary embolism
  • risk assessment
  • social media